Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

The integration of PD-1 inhibitors into standard chemotherapy and radiotherapy regimens has revolutionized nasopharyngeal ...

Novel Model Integrating TME Composition with TLS Gene Signatures Predicts Meaningful Survival Differences in Checkpoint Inhibitor-Treated Patients Cellworks Group Inc., a leader in Personalized ...

Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of ...

Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...

Immune cells work to fight infection and other diseases. Different subsets work together to elicit a healthy immune response; ...

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma Colorectal cancer (CRC) remains a major global health burden, being ...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

2025, A Year of Momentum: Advancing Toward a Potential Breakthrough in Ovarian Cancer Treatment ...

Chronic circadian disruption — such as night-shift work, irregular schedules, or frequent jet lag — accelerates the ...